STARTUP PROFILE

eNeura

COUNTRY
United States
FOUNDED
2000
CATEGORY
Neuromodulation
Providing FDA-cleared single-pulse transcranial magnetic stimulation devices for acute and preventive migraine treatment at home.
Visit website →
Neurofounders Insights
$   Funding   -
Series C+
MODALITY
TMS
FORM FACTOR
External device
INTERFACE DEPTH
Non-invasive
INDICATION
Pain/migraine
TARGET USER
Patients
REGULATORY STAGE
FDA cleared (510k)
eNeura sits in prescription home-use neuromodulation for migraine, with sTMS as a central stimulation approach distinct from peripheral nerve stimulation peers. Its profile is more mature than most migraine-device startups, with FDA-cleared indications and a long commercialization history.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
eNeura
No items found.